- Journal List
- Int J Surg Case Rep
- v.119; 2024 Jun
- PMC11096734
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Int J Surg Case Rep. 2024 Jun; 119: 109720.
Published online 2024 Apr 30. doi:10.1016/j.ijscr.2024.109720
PMCID: PMC11096734
PMID: 38714069
Nina Pfeifer,a,⁎ Thomas Steffen,a Larissa Clea Vines,b and Patrick Foliea
Author information Article notes Copyright and License information PMC Disclaimer
Abstract
Introduction
Marginal ulcers are an acid-related complication of laparoscopic Roux-en-Y gastric bypass. Few cases of acute perforation have been described, and there are few reports on viable surgical management. This case report demonstrates a two-step surgical procedure for treating a perforated late marginal ulcer in a patient with sepsis.
Presentation of case
A 39-year-old smoker presented to the emergency department six years after undergoing a Roux-en-Y gastric bypass. Diagnostic findings revealed ascites and changes in intestinal calibre, indicating the need for surgery. Intraoperatively, a perforated marginal ulcer covered by the liver was observed. Given the extent of the perforation and the patient's increased instability, discontinuity resection was performed. After stabilisation and improvement in the nutritional status, the gastrojejunostomy was restored nine weeks later.
Discussion
Treatment of Marginal ulcers is controversial, with no clear guidelines. However, severe complications require endoscopic or surgical treatment. The literature considers three main surgical treatment options for perforated marginal ulcers: surgical repair, surgical anastomotic revision, and gastric bypass reversal. Complicated situations, significant intraoperative findings, and unstable patients require tailored approaches.
Conclusion
A two-step procedure with discontinuity resection for damage control surgery, patient stabilisation, and improvement of nutritional status, followed by elective continuity restoration with a new gastrojejunostomy, is considered feasible in critically ill patients.
Keywords: Perforated marginal ulcer, Two-step procedure, Bariatric surgery, Case report
Highlights
•
Patients with perforated marginal ulcers may present in critically ill conditions.
•
A two-step procedure can be considered in these special cases.
•
Discontinuity resection and subsequent continuity restoration can be a safe option.
•
Patient stabilisation and improvement of the nutritional status are mandatory.
1. Introduction
Laparoscopic Roux-en-Y gastric bypass (LRYGB) is a safe procedure with acceptable short-term morbidity (4.4–7.9%) and reduced mortality (0.06–0.13%) over the last two decades [1,2]. Nevertheless, complications can have a significant impact on the patients. Acid-related complications, such as marginal ulcers (MU), may be underdiagnosed and remain asymptomatic at first (approximately 28%) [3], but then develop into severe complications.
The MU is located at or near the gastrojejunostomy site. The mucosa in this area is vulnerable to contact with gastric acid [4]. With the rising number of LRYGB procedures being performed worldwide, the incidence of MU has increased from 0.6 to 25% [5]. The occurrence of early MU (<12months) was significantly higher (4–12%) compared to late MU (>12months; <1%) [3].
The treatment of MU remains controversial, with a lack of randomised studies and clear guidelines [6]. Early diagnosis of MU can be achieved through drug therapy with proton pump inhibitors (PPI), sucralfate, or if present, Helicobacter pylori eradication [6]. Modification of patient-related risk factors, especially smoking cessation and renunciations of non-steroidal anti-inflammatory drugs (NSAIDs), has shown efficacy in 68–100% of cases with a relapse rate of 8% [[6], [7], [8], [9]]. Late diagnosis or the presence of severe complications usually requires endoscopy; 9–32% of MU patients require revision surgery [9,10]. Perforation of MU is a potentially life-threatening condition with high morbidity.
MUs at the gastrojejunal anastomosis have often been described; however, only a few cases have illustrated acute perforation, and there are few reports on viable surgical management. The literature outlines three main surgical treatment options for perforated MUs: surgical repair (suture +/− omental patch +/− drainage), surgical anastomotic revision, or reversal of the gastric bypass. Nevertheless, the surgical strategy depends on the patient's general condition, timing and symptoms upon presentation, size and location of the perforation, and the surgeon's expertise.
This report aimed to demonstrate a two-step surgical procedure for treating the severe complications of perforated late MU in a patient with sepsis. To the best of our knowledge, this has not been described in the treatment of perforated late MU after LRYGB.
Our case is reported in line with the SCARE criteria [11].
2. Case report
A 39-year-old active smoker (with a cumulative history of ten-pack years) without other comorbidities presented to the emergency department with acute-onset abdominal pain in the left upper quadrant. Due to severe obesity classified as World Health Organization (WHO) class III (183cm, 155kg, BMI 46.3kg/m2), he had undergone LRYGB six years prior, achieving a total weight loss of 51.6% by the time of presentation (currently weighing 75kg, with a BMI of 22.4kg/m2). However, no complications had been reported thus far. The patient denied taking any medications. He had missed bariatric follow-up appointments due to a change in residence. His surgical history included appendectomy and laparoscopic cholecystectomy ten years prior the patient underwent LRYGB.
Laboratory tests showed an increase in leucocytes (13G/l), no electrolyte shift, and low protein (63g/l) and albumin (36.9g/l) values. Computed tomography showed a jejunal change in calibre and ascites (Fig. 1). A bariatric surgeon decided to undergo an emergency laparoscopy.
Fig. 1
Preoperative CT-scan. Arrow: Stapler line. Asterisk: Extraluminal gas. Triangle: Adherence to the liver.
Laparoscopic exploration excluded an obstructive cause but revealed cloudy ascites with fibrinous peritonitis, highly suggestive of perforation. Adhesions from the gastrojejunostomy were found to thicken the left lobe of the liver (Fig. 2a). Careful preparation revealed a large-volume perforated cavity covered by the liver, likely caused by a perforated MU (Fig. 2b). Due to the increasingly tricky anesthesiologic management of the patient with sepsis and extensive peritonitis, conversion to laparotomy was performed. Laparotomy revealed a vast perforated MU with an extensive cavity covered by the left lobe of the liver. Owing to the increasing requirement for vasoactive life support, the decision for discontinuity resection of the gastrojejunostomy with a remaining 8cm pouch was made. The Roux limb was sutured to the antrum to facilitate the subsequent reconstruction. A gastrotube was inserted into the gastric remnant via percutaneous gastrostomy.
Fig. 2
First operation. a: Thickened left liver lobe with adherent gastrojejunostomy. b: Extensive cavity of perforated marginal ulcer covered by the liver.
Histopathology revealed chronic inflammation with sections of acute erosive inflammation but no malignancy.
The patient was discharged eight days after an uneventful postoperative course, having received seven days of intravenous antibiotic treatment (imipenem 4×500mg, day 0–day 6) and ongoing high-dose PPI therapy. Enteral feeding via percutaneous gastrostomy (Fig. 3) was initiated in accordance with the nutritional consultant's recommendations as shown in Table 1. Drinking in small sips was allowed for comfort, and a nasogastric tube was inserted preoperatively into the disconnected gastric pouch.
Fig. 3
Postoperative day 6 (before drainage removal). Arrow: Percutaneous gastrostomy. Asterisk: Drainage.
Table 1
Enteral nutrition via percutaneous gastrostomy (Calculated requirement per day: 2580kcal, 72–108g proteins, 2500–3200ml fluid).
POD | kcal | Protein (g) | Carb (g) | Fat (g) | Serum protein (g/l) | Serum albumin (g/l) | |
---|---|---|---|---|---|---|---|
0 | Surgery | – | – | – | – | 63 | 37 |
1–3 | 665 | 33 | 80 | 25 | 50 | 24 | |
4 | 1330 | 66 | 160 | 49 | |||
5 | 1995 | 99 | 240 | 73 | |||
6 | 1995 | 100 | 240 | 66 | |||
7–48 | 2660 | 134 | 320 | 88 | |||
49 | 72 | 41 | |||||
61 | Surgery | – | – | – | – | ||
62–63 | Start oral food intake | 1330 | 67 | 160 | 44 | ||
64–71 | 665 | 34 | 80 | 22 |
Open in a separate window
POD 0: Discontinuity resection; POD 6: change of product due to hospital discharge; POD 61: Restoration of continuity.
Abbreviations: POD – postoperative day; kcal – kilocalories; carb – carbohydrates.
Reference level: serum protein 63–83g/l; serum albumin 34–48g/l.
After optimisation of the nutritional condition, the gastrojejunostomy was laparoscopically restored nine weeks later (Fig. 4). Following an unremarkable contrast swallow examination, pureed food was permitted on postoperative day one. Enteral nutrition via the remaining gastric tube in the gastric remnant was continued for ten days postoperatively. The patient was discharged four days after the operation. Three weeks after the reconstructive surgery, the patient was in excellent condition. Therapy with a low-dose PPI, smoking cessation, and renunciations of NSAIDs were pronounced lifetime recommendations.
Fig. 4
Second operation. a: Restoring gastrojejunostomy with linear stapler. b: Restored gastrojejunostomy.
3. Discussion
Patients with perforated MU or massive bleeding require surgical revision and should undergo surgery performed by a specialist bariatric surgeon to improve outcomes [6,12].
Carr et al. [6] reviewed the available literature and developed an algorithm for managing MU after LRYGB. As the majority of MU is located distal to the gastrojejunostomy on the antimesenteric border of the small bowel, they are often accessible for laparoscopic closure or patch repair, which is reported as the optimal treatment for perforated MU with low mortality and morbidity, postoperative pain, hospital stay, and return to work [6]. The new creation of gastrojejunostomy results in longer operating time, higher blood loss, and longer length of stay, and should be reserved for non-emergency surgery [13].
In 2018, Altieri et al. [14] published the most extensive retrospective multicentre case series involving 292 patients who developed perforated MUs; with 179 receiving surgical treatment. Among them, 115 patients underwent anastomotic repair using sutures and omental patches, while 64 underwent anastomotic revision. Anastomotic repair resulted in a shorter operation time, reduced hospital stay and lower morbidity. Although technically challenging, anastomotic revision eliminates the ulcer and provides the benefit of a new anastomosis. However, a more aggressive surgical approach does not reduce the incidence of MU recurrence.
Only two cases have described gastric bypass reversal. Fan et al. [15] described a MU that perforated the liver, and gastric bypass reversal was performed as requested by the patient. In 2017, Wang et al. [16] performed gastric bypass reversal for a giant perforated recurrent MU following anastomotic revision.
None of these recommended treatment options were possible in our case without an increased risk of morbidity or mortality. Our intraoperative findings of a wide-perforated MU, combined with increasing circulatory instability and sepsis, forced us to convert to laparotomy. Closure and omental patch repair as the gold standard treatment for perforated MU was not feasible in this particular case because of the wide perforation, adherence to neighbouring organs, massive tissue induration, and critical condition of the patient. Considering anastomotic revision, we had reasonable concerns about anastomotic healing because of our patient's severe condition, marked by fulminant sepsis, an increasing need for catecholamines, peritonitis, and poor nutritional status, which were the main risk factors for anastomotic leakage. Furthermore, given the patient's deteriorating condition, we aimed to minimize the duration of surgery. During preoperative discussions regarding the possibility of gastric bypass reversal, the patient declined this option due to concerns of weight regain and subsequent decline of quality of life. Furthermore, this procedure is not feasible for patients with septic emergencies.
Comparable situations in non-bariatric surgery with hollow organ perforation and contamination of the situs in an unstable patient are managed by damage-control surgery using a two-step procedure. First, the perforation site is resected and the intestinal tract proximal to the perforation is either closed or diverted. After stabilisation, the continuity of the intestinal tract is restored. The transfer of a visceral surgical procedure according to the particular requirements of bariatric surgery and its patients was the only feasible surgical option for quickly stabilising our patient and counteracting inflammation. Sufficient enteral nutrition needed to be ensured after discontinuous resection. A gastrotube was inserted into the gastric remnant via percutaneous gastrostomy. After patient stabilisation and improvement in nutritional status, the second step was to create a new gastrojejunostomy with a lower risk of anastomotic leakage.
An experienced bariatric surgeon performed both surgeries. To the best of our knowledge, this is the first documented two-step procedure successfully performed for perforated MU in a critically ill patient.
4. Conclusion
A two-step procedure, as demonstrated in our case, involving discontinuity resection as damage control surgery followed by patient stabilisation and improvement of nutritional status, followed by elective continuity restoration with a new gastrojejunostomy, is considered feasible in critically ill patients.
Informed consent
Written informed consent was obtained from the patient to ensure access to his medical records. The patient's identity is protected.
Ethical approval
Ethical approval for this report is optional considering the nature of the study.
Funding
This study did not receive any specific grants from public, commercial, or nonprofit funding agencies.
Author contribution
NP: Literature search, manuscript draft.
LCV: critical revision of the manuscript.
TS: concept of presentation, critical revision of the manuscript.
PF: idea, writing support, data gathering.
Guarantor
Nina Pfeifer is the corresponding author of this article.
Research registration number
Not applicable.
Conflict of interest statement
The authors declare no conflict of interest.
Acknowledgements
None.
References
1. Singhal R., et al. 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data. Int. J. Obes. 2022;46:750–757. doi:10.1038/s41366-021-01048-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
2. Robertson A.G.N., et al. Perioperative mortality in bariatric surgery: meta-analysis. Br. J. Surg. 2021;108:892–897. doi:10.1093/bjs/znab245. [PubMed] [CrossRef] [Google Scholar]
3. Csendes A., Burgos A.M., Altuve J., Bonacic S. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes. Surg. 2009;19:135–138. doi:10.1007/s11695-008-9588-6. [PubMed] [CrossRef] [Google Scholar]
4. Edholm D., Ottosson J., Sundbom M. Importance of pouch size in laparoscopic Roux-en-Y gastric bypass: a cohort study of 14,168 patients. Surg. Endosc. 2016;30:2011–2015. doi:10.1007/s00464-015-4432-2. [PubMed] [CrossRef] [Google Scholar]
5. Coblijn U.K., Goucham A.B., Lagarde S.M., Kuiken S.D., Van Wagensveld B.A. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes. Surg. 2014;24:299–309. doi:10.1007/s11695-013-1118-5. [PubMed] [CrossRef] [Google Scholar]
6. Carr W.R.J., Mahawar K.K., Balupuri S., Small P.K. An evidence-based algorithm for the management of marginal ulcers following Roux-en-Y gastric bypass. Obes. Surg. 2014;24:1520–1527. doi:10.1007/s11695-014-1293-z. [PubMed] [CrossRef] [Google Scholar]
7. Rasmussen J.J., Fuller W., Ali M.R. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg. Endosc. Other Interv. Tech. 2007;21:1090–1094. doi:10.1007/s00464-007-9285-x. [PubMed] [CrossRef] [Google Scholar]
8. Csendes A., Torres J., Burgos A.M. Late marginal ulcers after gastric bypass for morbid obesity. Clinical and endoscopic findings and response to treatment. Obes. Surg. 2011;21:1319–1322. doi:10.1007/s11695-011-0429-7. [PubMed] [CrossRef] [Google Scholar]
9. Patel R.A., Brolin R.E., Gandhi A. Revisional operations for marginal ulcer after Roux-en-Y gastric bypass. Surg. Obes. Relat. Dis. 2009;5:317–322. doi:10.1016/j.soard.2008.10.011. [PubMed] [CrossRef] [Google Scholar]
10. Azagury D.E., Abu Dayyeh B.K., Greenwalt I.T., Thompson C.C. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43:950–954. doi:10.1055/s-0030-1256951. [PubMed] [CrossRef] [Google Scholar]
11. Sohrabi C., Mathew G., Maria N., Kerwan A., Franchi T., Agha R.A. The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines. Int. J. Surg. Lond. Engl. 2023;109(5):1136. doi:10.1097/JS9.0000000000000373. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Coblijn U.K., Lagarde S.M., De Castro S.M.M., Kuiken S.D., Van Tets W.F., Van Wagensveld B.A. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study. Surg. Obes. Relat. Dis. 2016;12:246–252. doi:10.1016/j.soard.2015.04.022. [PubMed] [CrossRef] [Google Scholar]
13. Wendling M.R., et al. Omental patch repair effectively treats perforated marginal ulcer following roux-en-Y gastric bypass. Surg. Endosc. 2013;27:384–389. doi:10.1007/s00464-012-2492-0. [PubMed] [CrossRef] [Google Scholar]
14. Altieri M.S., et al. The natural history of perforated marginal ulcers after gastric bypass surgery. Surg. Endosc. 2018;32:1215–1222. doi:10.1007/s00464-017-5794-4. [PubMed] [CrossRef] [Google Scholar]
15. Fan X., Kwan C., Riall T.S., Sellin J. A gastric ulcer at the anastomosis site perforated into the liver 3 years after Roux-en-Y gastric bypass surgery. Gastrointest. Endosc. 2008;68:769. doi:10.1016/j.gie.2008.02.089. [PubMed] [CrossRef] [Google Scholar]
16. Wang E., Blackham R., Tan J., Hamdorf J. Giant perforated marginal ulcer after laparoscopic Roux-en-Y gastric bypass. BMJ Case Rep. 2017;2017 doi:10.1136/bcr-2016-218829. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Articles from International Journal of Surgery Case Reports are provided here courtesy of Elsevier